Active Surveillance Feasible for Low-Risk Thyroid Cancer
THURSDAY, Sept. 22, 2022 (HealthDay News) — Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 in JAMA Oncology.Allen S. Ho, M.D., from Cedars-Sinai Medical Center in Los An…
Learn MoreSelf-Cut Mesh Noninferior for Pelvic Organ Prolapse Procedure
WEDNESDAY, Sept. 21, 2022 (HealthDay News) — Using the same titanium-coated polypropylene mesh, the surgical success rate with self-cut mesh is noninferior to that with a commercial mesh kit for the transvaginal treatment of severe pelvic organ prola…
Learn MoreRecommendations Issued for Perioperative Antithrombotic Management
TUESDAY, Sept. 20, 2022 (HealthDay News) — In a clinical practice guideline issued by the American College of Chest Physicians and published online Aug. 11 in CHEST, recommendations are presented for perioperative management of patients receiving l…
Learn MoreRecommendations Issued for Perioperative Antithrombotic Management
TUESDAY, Sept. 20, 2022 (HealthDay News) — In a clinical practice guideline issued by the American College of Chest Physicians and published online Aug. 11 in CHEST, recommendations are presented for perioperative management of patients receiving l…
Learn MoreUna disección en la aorta, una arteria del corazón, con frecuencia es letal, pero la supervivencia mejora
VIERNES, 16 de septiembre de 2022 (HealthDay News) — Una disección (desgarro) de la aorta con frecuencia puede resultar letal, pero un nuevo estudio encontró que la supervivencia ha mejorado de forma significativa en las últimas décadas.Pero de cualq…
Learn MoreWhen Preferred Language Is Not English, Children Experience Surgical Delays
MONDAY, Sept. 19, 2022 (HealthDay News) — Children whose families prefer a language other than English experience a longer delay between anterior cruciate ligament (ACL) injury and surgery compared with families preferring English, according to a stu…
Learn MoreUn nuevo método de tratamiento mejora las probabilidades contra 2 tipos de cáncer de piel
JUEVES, 15 de septiembre de 2022 (HealthDay News) — Parece que a los pacientes con un cáncer de piel les va mejor si reciben inmunoterapia antes de la extirpación quirúrgica de su cáncer, muestran dos ensayos clínicos.De hecho, a algunos les va tan b…
Learn MoreTear in Heart’s Aorta Often Deadly, Though Survival Improving
FRIDAY, Sept. 16, 2022 (HealthDay News) — A torn aorta can often be deadly, but a new study has found that survival has improved significantly over the past several decades.But it can still be five times more deadly if not repaired surgically, the re…
Learn MoreNew Treatment Approach Boosts Odds Against 2 Types of Skin Cancer
THURSDAY, Sept. 15, 2022 (HealthDay News) — Skin cancer patients appear to fare better if they receive immunotherapy before their cancers are surgically removed, a pair of clinical trials show.In fact, some do so well that their immune system essenti…
Learn MoreRisk Factors ID’d for New Long-Term Opioid Use After Lung Cancer Surgery
TUESDAY, Sept. 13, 2022 (HealthDay News) — Potential risk factors for new long-term opioid use after lung cancer surgery have been identified, and new long-term opioid use is associated with an increased risk for all-cause mortality, according to a s…
Learn More